Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-2025352636-A1 · Nov 20, 2025 · US
This page is not indexed by search engines while we improve data quality.
Probst Jochen patents
Probst Jochen is listed as an inventor on 87 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Probst Jochen |
| Total patents | 87 |
| First publication | Jan 5, 2016 |
| Latest publication | Nov 20, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Combination of vaccination and inhibition of the PD-1 pathway
US-12447209-B2 · Oct 21, 2025 · US
Rna containing composition for treatment of tumor diseases
US-2025213724-A1 · Jul 3, 2025 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
US-2025152745-A1 · May 15, 2025 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-12201680-B2 · Jan 21, 2025 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
US-12109275-B2 · Oct 8, 2024 · US
Composition for treating prostate cancer (PCa)
US-12048738-B2 · Jul 30, 2024 · US
Rna containing composition for treatment of tumor diseases
US-2023338579-A1 · Oct 26, 2023 · US
PRIME-BOOST REGIMENS INVOLVING ADMINISTRATION OF AT LEAST ONE mRNA CONSTRUCT
US-2023210965-A1 · Jul 6, 2023 · US
Combination of vaccination and inhibition of the pd-1 pathway
US-2023158131-A1 · May 25, 2023 · US
Recent patents
Latest publications not already listed above.
Prime-boost regimens involving administration of at least one mRNA construct
US-11559570-B2 · Jan 24, 2023 · US
NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS IMMUNOSTIMULATING AGENT/ADJUVANT
US-2022401555-A1 · Dec 22, 2022 · US
Rna-coded antibody
US-2022372158-A1 · Nov 24, 2022 · US
Combination of vaccination and inhibition of the PD-1 pathway
US-11458195-B2 · Oct 4, 2022 · US
RNA-coded antibody
US-11421038-B2 · Aug 23, 2022 · US
Composition for treating lung cancer, particularly of non-small lung cancers (nsclc)
US-2022096616-A1 · Mar 31, 2022 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
US-2021393755-A1 · Dec 23, 2021 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded tumour antigen
US-11110156-B2 · Sep 7, 2021 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-2021128716-A1 · May 6, 2021 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
US-2021060181-A1 · Mar 4, 2021 · US
RNA containing composition for treatment of tumor diseases
US-10918740-B2 · Feb 16, 2021 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-10912826-B2 · Feb 9, 2021 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
US-10898589-B2 · Jan 26, 2021 · US
RNA containing composition for treatment of tumor diseases
US-10869935-B2 · Dec 22, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-2020345831-A1 · Nov 5, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-10799577-B2 · Oct 13, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
US-2020276336-A1 · Sep 3, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
US-10682406-B2 · Jun 16, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded protein
US-10653799-B2 · May 19, 2020 · US
Nucleic acid comprising or coding for a histone stem-loop and a poly(A) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
US-10610605-B2 · Apr 7, 2020 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Curevac Ag | 77 |
| CureVac SE | 11 |
| Probst Jochen | 4 |
| Hoerr Ingmar | 3 |
| Curevac Gmbh | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61K2039/53 | 75 |
| A61P35/00 | 71 |
| Y02A50/30 | 61 |
| A61P33/00 | 49 |
| A61P31/00 | 45 |